Clinical Trial Update: Evaluation of SclerFIX Graft in Scleral Thinning After Exeresis of Tumors of the Ocular Surface [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating SclerFIX Graft for scleral thinning following exeresis of ocular surface tumors was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Scleral Thinning

Drugs mentioned

• SclerFIX Graft

Snippet

Sponsor: TBF Genie Tissulaire | Conditions: Scleral Thinning | Phase 2 | Status: TERMINATED